Quantinno Capital Management LP Has $433,000 Holdings in Teleflex Incorporated (NYSE:TFX)

Quantinno Capital Management LP trimmed its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 82.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,432 shares of the medical technology company's stock after selling 11,251 shares during the period. Quantinno Capital Management LP's holdings in Teleflex were worth $433,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of TFX. Headlands Technologies LLC acquired a new position in Teleflex during the 4th quarter worth $29,000. Avior Wealth Management LLC increased its holdings in Teleflex by 81.2% during the 4th quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock valued at $50,000 after acquiring an additional 125 shares in the last quarter. IFP Advisors Inc lifted its position in shares of Teleflex by 238.5% in the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after acquiring an additional 217 shares in the last quarter. Exchange Traded Concepts LLC lifted its stake in shares of Teleflex by 38.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after buying an additional 94 shares during the period. Finally, R Squared Ltd acquired a new stake in Teleflex in the 4th quarter worth about $64,000. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Trading Down 0.6%

TFX stock traded down $0.70 during trading on Friday, hitting $121.83. The company had a trading volume of 59,783 shares, compared to its average volume of 920,391. The stock has a market cap of $5.38 billion, a price-to-earnings ratio of 24.22, a PEG ratio of 1.73 and a beta of 1.17. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The firm has a 50-day moving average price of $129.94 and a 200-day moving average price of $157.99. Teleflex Incorporated has a 12 month low of $119.08 and a 12 month high of $249.90.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.88 by $0.03. The firm had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company's quarterly revenue was down 5.0% compared to the same quarter last year. During the same period in the previous year, the business posted $3.21 EPS. As a group, analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date of this dividend is Tuesday, May 20th. Teleflex's dividend payout ratio (DPR) is currently 42.90%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on TFX shares. Raymond James downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. Royal Bank of Canada lowered their price objective on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a research note on Friday, May 2nd. Morgan Stanley decreased their price target on Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research report on Monday, May 5th. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. Finally, Truist Financial lowered their price target on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research note on Monday, May 5th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $164.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.